Metraipolis › archive › dc_5ecf4bc27962

BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment — Europe PMC PMID:41744844

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41744844
DOI
10.3390/curroncol33020080
License (as archived)
solo-consultazione
Archived
2026-11-06T10:10:05.608Z
SHA-256 of the archived text
9e1b95795bcc31b6b8d683683142bfc63507a227d8e5b654731c7e5fdf17a180
Stable URL of this page
https://metraipolis.com/documento/dc_5ecf4bc27962

How to cite

BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment — Europe PMC PMID:41744844 — Europe PMC (en), https://europepmc.org/article/MED/41744844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5ecf4bc27962 (Metraipolis archive dc_5ecf4bc27962, sha256 9e1b95795bcc31b6b8d683683142bfc63507a227d8e5b654731c7e5fdf17a180)
BibTeX
@misc{dc5ecf4bc27962,
  title = {BCMA-Directed CAR T-Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma and Renal Impairment — Europe PMC PMID:41744844},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41744844},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5ecf4bc27962; sha256 9e1b95795bcc31b6b8d683683142bfc63507a227d8e5b654731c7e5fdf17a180},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41744844. Agents can read the archived copy with the MCP tool read_document.